Journal: Oncotarget
Article Title: Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL
doi: 10.18632/oncotarget.25849
Figure Lengend Snippet: 32D/TetOff-p210 cells were Tet-supplied or depleted and then cultured in the presence or absence of imatinib (1 μM) for 96 h. (A) Giemsa staining was performed. Cells with segmented nuclei (indicated by arrows) are shown in each panel. Scale bar, 10 μm. (B) Cells were triple-stained with anti-CD11b-BV421, anti-Ly6C-APC, and anti-Ly6G-PE, or isotype anti-rat IgG2b-BV421, anti-rat IgM-APC, and anti-rat IgG2a-PE. Stained cells were analyzed by flow cytometry. The obtained data were processed by selection of PI - and CD11b + cell population, and then the cell surface expression of Ly6C and Ly6G within the CD11b + cell population was analyzed. Numbers in the plots indicate the percentages of gated cells. (C) Three independent triple-staining experiments, as exemplified in panel B, were performed, and statistical analysis was executed. * P < 0.01. Data are shown as mean ± SEM ( n = 3).
Article Snippet: Mouse myeloid progenitor 32D cells were pharchased from RIKEN BioResouce Centaer Cell Bank (RBRC-RCB1145; Tsukuba, Ibaraki, Japan) and cultured in RPMI1640 supplemented with 10%(v/v) FBS and 10%(v/v) IL-3 culture supplement (Corning, NY, USA), defined as the 32D growth media, at 37°C under 5% CO2 in air.
Techniques: Cell Culture, Staining, Flow Cytometry, Selection, Expressing